Cargando…
Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH
Human cytomegalovirus (HCMV) is a β-herpesvirus that increases morbidity and mortality in immunocompromised individuals including transplant recipients and newborns. New anti-HCMV therapies are an urgent medical need for diverse patient populations. HCMV infection of a broad range of host tissues is...
Autores principales: | Parsons, Andrea J., Ophir, Sabrina I., Duty, J. Andrew, Kraus, Thomas A., Stein, Kathryn R., Moran, Thomas M., Tortorella, Domenico |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038728/ https://www.ncbi.nlm.nih.gov/pubmed/35468974 http://dx.doi.org/10.1038/s42003-022-03294-z |
Ejemplares similares
-
Functional screening for anti-CMV biologics identifies a broadly neutralizing epitope of an essential envelope protein
por: Gardner, Thomas J., et al.
Publicado: (2016) -
CD46 facilitates entry and dissemination of human cytomegalovirus
por: Stein, Kathryn R., et al.
Publicado: (2019) -
Human cytomegalovirus gH stability and trafficking are regulated by ER-associated degradation and transmembrane architecture
por: Gardner, Thomas J., et al.
Publicado: (2016) -
Subdominant Antigens in Bacterial Vaccines: AM779 Is Subdominant in the Anaplasma marginale Outer Membrane Vaccine but Does Not Associate with Protective Immunity
por: Albarrak, Saleh M., et al.
Publicado: (2012) -
Immunodominant Cytomegalovirus Epitopes Suppress Subdominant Epitopes in the Generation of High-Avidity CD8 T Cells
por: Freitag, Kirsten, et al.
Publicado: (2021)